Stay updated on SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial

Sign up to get notified when there's something new on the SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Footer revision label updated from Revision: v3.2.0 to Revision: v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-24T18:24:54.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The government funding status notice was removed from the page; previously, the notice warned that information may not be up to date due to funding lapses and directed users to cc.nih.gov and opm.gov for operating status.
    Difference
    0.1%
    Check dated 2025-11-17T17:59:58.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected in the study details page; changes appear to be routine data updates or UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T12:38:57.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Replace Sage Therapeutics with Supernus Pharmaceuticals, Inc. and update date references to 2025-10-01 and 2025-10-14, with an “Last Update Posted (Estimated)” marker. Interpreted as a branding/ownership or documentation update rather than substantive content changes.
    Difference
    1%
    Check dated 2025-10-20T06:39:51.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Key updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.
    Difference
    2%
    Check dated 2025-10-05T17:28:13.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    The page update adds a new version tag (v3.1.0) and removes several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with an older revision tag (v3.0.2), indicating a cleanup of outdated topics rather than adding new core content.
    Difference
    0.4%
    Check dated 2025-09-28T10:12:58.000Z thumbnail image

Stay in the know with updates to SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial page.